Fundraising FoxResolution Therapeutics
1 known investors
Find your way into Resolution Therapeutics
Sign up to see every warm intro you have to Resolution Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Resolution Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Resolution develops a macrophage cell therapy to treat end-stage liver disease, aiming to reduce the need for liver transplantation and improve patient outcomes. The company focuses on regenerative medicine for inflammatory and fibrotic diseases.
Investors · 1
Synconalisted by SynconaLondon
How we know: Syncona's portfolio page · funding news · labiotech.eu · open dataset · 5k.vc investor directory · Not right? Tell us
Funding
SEC filings, press & company announcementsSource: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Resolution Therapeutics do?
- Resolution develops a macrophage cell therapy to treat end-stage liver disease, aiming to reduce the need for liver transplantation and improve patient outcomes. The company focuses on regenerative medicine for inflammatory and fibrotic diseases.
- Who are Resolution Therapeutics's investors?
- Resolution Therapeutics's investors include Syncona.